PKKK/300/UP/060 Screening of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Cosmetic Products Using HPLC
- Tapis semua fasa bergerak (akueus dan organik) menggunakan penuras membran 0.45 µm dan degas dalam kukus ultrasonik selama sekurang-kurangnya 15–20 minit.
- Lakukan Auto Purge / Manual Purge setiap kali pelarut ditambah atau ditukar jenis bagi menyingkirkan buih udara.
- Pastikan garisan dasar (baseline) dan tekanan pam stabil (RSD < 2%) sebelum memulakan suntikan sampel kelompok.
- Bagi sampel matriks kapsul lembut (softgel), gunakan Chloroform kerana gelatin/minyak tidak larut dalam Methanol.
|
NPRA PUSAT KAWALAN KUALITI |
ARAHAN KERJA: SCREENING OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) IN COSMETIC PRODUCTS USING HPLC | |
| No. Dokumen: PKKK/300/UP/060 | Terbitan / Semakan: Terbitan 3 Semakan 0 | |
| Tarikh Kuatkuasa: 10 April 2026 | Bahagian / Unit: SPPK · Unit Penyaringan | |
0.0 SEJARAH PINDAAN & SEMAKAN
Issue 2 Revision 0 :
Update document number from PKKK/300/HMS/086 to PKKK/300/KOS/032
Update paragraph 5.0 Responsibilities
Update paragraph 7.0 Quality Records
Issue 2 Revision 1 :
Update paragraph 6.3.4
Update paragraph 6.4.3
Issue 3 Revision 0:
Update document number from PKKK/300/KOS/032 to PKKK/300/UP/060.
Update effective date from 1 Ogos 2024 to 10 April 2026.
Update paragraph 7.0 Quality Records :
KOS/X004 to UP/X010
KOS/X003 to UP/X009
KOS/002A to UP/002B
KOS/X009 to UP/X013
1.0 OBJECTIVE
◼ The test is performed to screen the presence of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in cosmetic products by using HPLC.
2.0 SCOPE
◼ The screening method is used to identify NSAIDs in cosmetic products received from customers such as Surveillance & Complaint Section, Pharmacy Enforcement and others.
NA
4.0 FLOW CHART
NA
Responsibility
Head of Section
Check and approve investigational reports, test reports and results of sample that does not comply with the specification.
Head of Unit / Pharmacist in charge
Distribute a list of samples to be tested to pharmacists through the online QUEST system.
Check and approve test reports and results of samples that comply with the specification.
Check the investigational report for sample that does not comply with the specification.
Pharmacist
Check test reports and results of samples that has been tested in the laboratory.
Prepare the investigational report for sample that does not comply with the specification.
Analysts
Perform sample testing according to the approved procedure
Prepare test reports
6.0 PROCEDURE
High Pressure Liquid Chromatograph with photo diode array detector
Ultrasonic bath
Zorbax Eclipse Plus C18;150 mm x 4.6 mm i.d., 5 µm
Micropipette
Nylon filter, 47 mm diameter, 0.45 µm pore size or equivalent
10 mL, 50 mL Volumetric flasks
50 mL glass stoppered conical flask
Acetonitrile (HPLC grade)
Methanol (HPLC grade)
Sodium Dihydrogen Phosphate Dihydrate (NaH2PO4.2H2O)
Water (Ultrapure water, 18 mega ohm)
Orthophosphoric acid 85% (H3PO4)
Reference material: Aspirin, Ibuprofen, Diclofenac Sodium, Mefenamic Acid, Naproxen, Paracetamol, Piroxicam, Sulindac, Ketoprofen, Indomethacin, Phenylbutazone
Chromatographic Parameters
Test Method
Mobile Phase Preparation
6.3.1.1Mobile Phase A (Sodium Dihydrogen Phosphate Buffer): Dissolve 3.9 g NaH2PO4.2H2O in 1000 mL of water. Mix well and adjust to pH 3.2 with Orthophosphoric acid. Filter and degassed before use.
6.3.1.2 Mobile Phase B: Filter and degassed 1000 mL Acetonitrile.
Reference Standard Stock Solution Preparation
6.3.2.1 Weigh separately 2 mg of Aspirin, Ibuprofen, Diclofenac Sodium, Mefenamic Acid, Naproxen, Paracetamol, Piroxicam, Sulindac, Ketoprofen, Indomethacin, Phenylbutazone Reference Standard into 10 mL volumetric flask. Add 5 mL of Methanol and sonicate for 20 minutes. Make up to volume with Methanol (0.2 mg/mL / 200 ppm).
Pipette 3.75mL of Indomethacin standard stock solution and Naproxen standard stock solution into a 50 mL volumetric flask and make up to volume with Methanol. (0.015 mg/mL / 15 ppm).
Pipette 3.75 mL of the remaining Reference Standard Stock Solution (except for Indomethacin and Naproxen) into a 50 mL flask and make up to volume with Methanol (0.015 mg/mL / 15 ppm).
Limit of Detection (LOD) Solution Preparation
Limit of Detection (LOD) Solution Preparation (LOD-Mix Standard A2)
Pipette 300 µL of Mix Standard A1 solution into a vial and add 1200 µL of Methanol (0.003 mg/mL / 3 ppm).
6.3.4.2 Limit of Detection (LOD) Solution Preparation (LOD-Mix Standard B2)
Pipette 300 µL of Mix Standard B1 Solution into a vial and add 1200 µL of Methanol. (0.003mg/mL / 3ppm).
Note:
The weight of the reference standard can be modified to minimize the usage of the reference standard.
Sample Preparation
6.3.5.1 Weigh approximately 0.5 g of sample into a 50 mL glass stoppered conical flask. Add 20 mL of Methanol. Sonicate for 10 minutes. Filter the solution with a 0.45 µm nylon filter prior to injecting into the HPLC.
Note: The weight of the sample can be modified due to the availability and amount of the sample received.
System Suitability Test (SST)
ii) Theoretical plates NLT 1500
iii) Resolution NLT 1.5
Injection Sequence
Results Interpretation
Aspirin, Ibuprofen, Diclofenac Sodium, Mefenamic Acid & Naproxen are analysed and interpreted at 220 nm.
Paracetamol, Piroxicam, Sulindac, Ketoprofen, Indomethacin and Phenylbutazone are analysed and interpreted at 254 nm.
Compare the Retention Time, Area and Spectrum obtained from the sample chromatogram against the LOD-Mix Standard Solution (A2/B2) chromatogram. A compound is reported as detected in the sample if:
Retention time corresponds to standard with difference less than +/- 1%
The sample peak area is more than LOD-Mix Standard (A2/B2)
The spectrum of the sample with a similarity of more than 0.999 to the spectrum of standard
The analysis shall be repeated by a second analyst using the same method when the sample was detected with NSAIDs in the first analysis.
Result documented in Certificate of Analysis:
If NSAIDs not detected : ‘Tidak dikesan’
If NSAIDs detected : ‘Dikesan’
7.0 QUALITY RECORDS
Borang Tatacara Pengujian menggunakan kaedah HPLC : UP/X010
Rumusan Laporan Pengujian Kromatografi : UP/X009
Laporan Siasatan Sampel Tidak Lulus Ujian Kromatografi : UP/002B
Borang Keputusan Ujian Kosmetik : UP/X013
8.0 ATTACHMENTS
Chromatogram of Mix Reference Standard Solutions
Spectrum of Standards
Chromatogram of LOD-Mix Standard (A2/B2), Diluent & Sample
Chromatogram of Mix Reference Standard Solutions
Spectrum of Standards
Naproxen
Indomethacin
Aspirin
Ibuprofen
Diclofenac Sodium
Mefenamic Acid
Paracetamol
Sulindac
Piroxicam
Ketoprofen
Phenylbutazone
Chromatogram of LOD-Mix Standard (A2/B2), Diluent & Sample
Jadual Kromatografi & Rujukan Data
| HISTORY OF REVISION | HISTORY OF REVISION | HISTORY OF REVISION | HISTORY OF REVISION | HISTORY OF REVISION | HISTORY OF REVISION |
|---|---|---|---|---|---|
| Issue | Revision | Written by | Reviewed by | Approved by | Effective date |
| 1 | 0 | Gopinatha Ganesh | Nor Izyani Hanafi | Wan Nurul Aina Mior Abdullah | 1 April 2023 |
| 2 | 0 | Leong Lip Wai | Gopinatha Ganesh | Nor Izyani Hanafi | 1 April 2024 |
| 2 | 1 | Leong Lip Wai | Gopinatha Ganesh | Nor Izyani Hanafi | 1 Ogos 2024 |
| 3 | 0 | Gopinatha Ganesh | Tan Lu Yi | Ida Syazrina Ibrahim | 10 April 2026 |
| REFERENCES | REFERENCES |
|---|---|
| Document No. | Title |
| Standard Operating Procedure for HPLC |
| ◼ Column | : | Zorbax Eclipse Plus C18;150 mm x 4.6 mm i.d., 5 µm |
|---|---|---|
| ◼ System | : | Gradient |
| ◼ Mobile phase | : | Mobile Phase A (Buffer):Mobile Phase B (Acetonitrile) |
| ◼ Temperature | : | 40 oC |
| ◼ Flow rate | : | 1.0 mL/min |
| ◼ Detection | : | UV, 220 nm & 254 nm |
| ◼ Injection volume | : | μL |
| Injection sequence | Injection ID | No. of injection | Run time (min) |
|---|---|---|---|
| 1 | Diluent | 1 | 20 |
| 2 | LOD-Mix Standard A2 | 1 | 20 |
| 3 | LOD-Mix Standard B2 | 1 | 20 |
| 4 | Mix reference standard solution A1 (Check for SST) | 6 | 120 |
| 5 | Mix reference standard solution B1 (Check for SST) | 6 | 120 |
| 6 | Sample Solution | 1 | 20 |
| 7 | Sample Solution (Final) | 1 | 20 |
| 8 | Mix reference standard solution A1 | 1 | 20 |
| 9 | Mix reference standard solution B1 | 1 | 20 |